Cite
Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.
MLA
Vashishtha, Richa, et al. “Efficacy and Safety of Thrice Weekly DOTS in Tuberculosis Patients with and without HIV Co-Infection: An Observational Study.” BMC Infectious Diseases, vol. 13, no. 1, Oct. 2013, pp. 468–76. EBSCOhost, https://doi.org/10.1186/1471-2334-13-468.
APA
Vashishtha, R., Mohan, K., Singh, B., Devarapu, S. K., Sreenivas, V., Ranjan, S., Gupta, D., Sinha, S., & SuSharma, S. K. (2013). Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study. BMC Infectious Diseases, 13(1), 468–476. https://doi.org/10.1186/1471-2334-13-468
Chicago
Vashishtha, Richa, Krishna Mohan, Bhagteshwar Singh, Satish K. Devarapu, Vishnubhatla Sreenivas, Sanjay Ranjan, Deepak Gupta, Sanjeev Sinha, and Surendra K. SuSharma. 2013. “Efficacy and Safety of Thrice Weekly DOTS in Tuberculosis Patients with and without HIV Co-Infection: An Observational Study.” BMC Infectious Diseases 13 (1): 468–76. doi:10.1186/1471-2334-13-468.